VINDESINE-MITOXANTRONE (VM) VERSUS VINDESINE-4'-EPIDOXORUBICIN (VE) IN METASTATIC BREAST-CANCER - A PROSPECTIVE RANDOMIZED TRIAL

被引:0
|
作者
HAUSMANINGER, H [1 ]
LEHNERT, M [1 ]
机构
[1] LANDESKRANKENANSTALTEN,DEPT INTERNAL MED 3,A-5020 SALZBURG,AUSTRIA
来源
ONKOLOGIE | 1988年 / 11卷 / 01期
关键词
D O I
10.1159/000216485
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:59 / 60
页数:2
相关论文
共 50 条
  • [1] VINDESINE-EPIRUBICIN VERSUS VINDESINE-MITOXANTRONE IN METASTATIC BREAST-CANCER
    HAUSMANINGER, H
    LEHNERT, M
    STEGER, G
    SEVELDA, P
    MICHLMAYR, G
    HEHENWARTER, W
    FRIDRIK, M
    SAMONIGG, H
    SCHILLER, L
    MANFREDA, D
    HAIDINGER, R
    KIENZER, R
    NEISS, A
    [J]. ONKOLOGIE, 1989, 12 (05): : 225 - 229
  • [2] PROSPECTIVE RANDOMIZED STUDY WITH CROSSOVER IN METASTATIC BREAST-CANCER - MITOXANTRONE PLUS VINDESINE VERSUS 4'-EPIDOXORUBICIN PLUS VINDESINE AND MITOXANTRONE PLUS PREDNIMUSTINE VERSUS 4'-EPIDOXORUBICIN PLUS PREDNIMUSTINE
    LEHNERT, M
    HAUSMANINGER, H
    LENZHOFER, R
    [J]. ONKOLOGIE, 1987, 10 (05): : 276 - 277
  • [3] ADRIAMYCIN, CYCLOPHOSPHAMIDE AND VINDESINE (ACV) VERSUS MITOXANTRONE, CYCLOPHOSPHAMIDE AND VINDESINE (NCV) IN ADVANCED BREAST-CANCER
    JANSSENS, JP
    CHIN, Y
    DELEU, M
    BONTE, J
    STAELENS, Y
    [J]. ANTICANCER RESEARCH, 1993, 13 (6B) : 2477 - 2483
  • [4] LONGTERM RESPONSES TO VINDESINE-MITOXANTRONE-MITOMYCIN FOR METASTATIC BREAST-CANCER
    BELPOMME, D
    GISSELBRECHT, C
    HACENE, K
    MARTY, M
    NETTERPINON, G
    PUJADELAURAINE, E
    LEROL, A
    GEORGE, C
    MARAL, J
    [J]. BULLETIN DU CANCER, 1987, 74 (06) : 693 - 693
  • [5] PHASE-II TRIAL OF MITOXANTRONE, VINDESINE AND METHOTREXATE IN ADVANCED METASTATIC BREAST-CANCER (AMBC)
    NABHOLTZ, JM
    FARGEOT, P
    VANOLI, A
    FRIC, D
    DRAMAIS, D
    FRIEDMAN, S
    MAYER, F
    DEGISLAIN, C
    GUERRIN, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 123 - 123
  • [6] VINDESINE IN THE TREATMENT OF METASTATIC BREAST-CANCER
    HANSEN, PV
    BRINCKER, H
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (10): : 1221 - 1225
  • [7] Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer
    Hausmaninger, H
    Lehnert, M
    Steger, G
    Sevelda, P
    Tschurtschenthaler, G
    Hehenwarter, W
    Fridrik, M
    Samonigg, H
    Schiller, L
    Manfreda, D
    Haidinger, R
    Kienzer, R
    Kemmler, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2169 - 2173
  • [8] PROLONGED REMISSIONS INDUCED BY THE VINDESINE, MITOXANTRONE, MITOMYCIN COMBINATION IN METASTATIC BREAST-CANCER
    DELPOMME, D
    COUR, V
    GISSELBRECHT, C
    LEROL, A
    MIGNOT, L
    MARTY, M
    GODEFFROY, W
    MARAL, J
    [J]. PRESSE MEDICALE, 1987, 16 (13): : 635 - 635
  • [9] VINDESINE AND ADRIAMYCIN IN THE THERAPY OF METASTATIC BREAST-CANCER
    WANDER, HE
    NAGEL, GA
    [J]. ONKOLOGIE, 1982, : 5 - 7
  • [10] VINDESINE IN COMBINATION WITH ADRIAMYCIN FOR TREATMENT OF METASTATIC BREAST-CANCER
    POWLES, TJ
    COOMBES, RC
    GORDON, C
    SMITH, IE
    [J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1982, 8 (05) : 571 - 575